Cuprina Holdings (Cayman) LTD
Business
Cuprina Holdings (Cayman) LTD operates as a biomedical and biotechnology company focused on development and commercialization of products for chronic wound management and health and beauty applications. It offers medical-grade sterile blowfly larvae bio-dressing products marketed as MEDIFLY, cosmeceutical items (hydrating balm, muscle energy cream, pain relief patch) and a pipeline including medical leech therapy and bullfrog collagen-based wound dressings. Its business is organized into chronic wound care and cosmeceuticals segments. Cuprina sells to public and private hospitals and clinics and to consumers via distributors, retailers, gyms and online platforms, with operations primarily in Singapore and Hong Kong and distribution relationships in other Asian and Middle Eastern markets.
Summary from filing dated 2025-05-14
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $38.8K |
| Net income | $-3.63M |
| Total assets | $6.61M |
| Total liabilities | $2.68M |
| Stockholders' equity | $3.93M |
| Operating cash flow | $-7.10M |